Adiponectin–Leptin Ratio and Its Association With Cardiometabolic Risk in  Patients With Metabolic Syndrome: A Cross-Sectional Biochemical Study

Nadeem Abbas, Mishal Safdar, Rimsha Kanwal, Neelam Ijaz, Rahma Zahid Butt, Jahanzaib

Adiponectin–Leptin Ratio and Its Association With Cardiometabolic Risk in Patients With Metabolic Syndrome: A Cross-Sectional Biochemical Study

Authors

Nadeem Abbas, Mishal Safdar, Rimsha Kanwal, Neelam Ijaz, Rahma Zahid Butt, Jahanzaib

Keywords:

Adiponectin; ratio; leptin; metabolic syndrome; insulin resistance; HOMA-IR; cardiometabolic risk; biochemical markers.

Abstract

Background: Metabolic syndrome is acluster of metabolic abnormalities associatedwith an increased risk of type 2 diabetesmellitus and cardiovascular disease. Adiponectin and leptin are adipose-derivedhormones with contrasting metabolic effects.

References

1. Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):16401645. doi:10.1161/CIRCULATIONAHA.109.192 644.

Downloads

Published

2026-10-24

How to Cite

Nadeem Abbas, Mishal Safdar, Rimsha Kanwal, Neelam Ijaz, Rahma Zahid Butt, Jahanzaib. (2026). Adiponectin–Leptin Ratio and Its Association With Cardiometabolic Risk in Patients With Metabolic Syndrome: A Cross-Sectional Biochemical Study . International Journal of Pharmacy Research & Technology (IJPRT), 16(2), 6947–6959. Retrieved from https://www.ijprt.org/index.php/pub/article/view/3432